Economic burden of diabetic patients in India: A review.
The Indian diabetic population is predicted to reach more than 80 million by the year 2030. It indicates that immediate health policy restructuring and investment will be needed if the best use is to be made of scarce health care resources with accompanying economic constraints. The costs of treatment of diabetes exists among the patients of all socioeconomic groups.A recent study showed that, in India, the total annual expenditure by patients on diabetes care was, on average, Rs. 10,000 in urban areas and Rs. 6260 in rural areas. The studies related to diabetes indicate that the direct and indirect cost implications of diabetes are multifold worldwide. The direct costs are related to the medical and non-medical cost of people with diabetes, mostly the burden on individual and at the family level. The indirect costs are related to the society and government, which are associated to loss of productivity. The review also finds that the annual direct and indirect medical costs per patient increase with the number of microvascular and macrovascular complications. A study in India during the years 2008 and 2009 found that total costs for patients without complications were Rs. 4493 compared to Rs. 14,692for patients with complications.The review reveals that it is imperative to work effectively towards implementing a holistic programme for diabetes prevention and reduce diabetic expenditure burden in the community.